Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Vibegron relieves OAB symptoms in men treated for BPH
Treatment with vibegron significantly improves overactive bladder (OAB) symptoms in men who are being treated for benign prostatic hyperplasia (BPH), including daily micturitions and urgency episodes, results from the phase III COURAGE trial have shown. It is well tolerated and has an acceptable safety profile, with adverse event (AE) rates similar to placebo.
Vibegron relieves OAB symptoms in men treated for BPH
27 Jul 2024
Real-world data favour tirzepatide over semaglutide for weight loss
Tirzepatide appears to yield substantially greater reductions in weight than semaglutide in the real-world treatment of overweight or obesity in adults with or without diabetes, according to a study.
Real-world data favour tirzepatide over semaglutide for weight loss
25 Jul 2024
Is it safe for coeliac disease patients to take antiobesity drugs?
Patients with coeliac disease (CD) on a gluten-free diet and are treated with antiobesity medications (AOMs) show comparable weight loss outcomes to those without CD, reports a study.
Is it safe for coeliac disease patients to take antiobesity drugs?
25 Jul 2024
Do antidepressants induce mania in patients with bipolar depression?
Use of antidepressants does not contribute to the risk of mania, as shown in a study. There is also no association observed between antidepressants and recurrence of bipolar depression.